These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


329 related items for PubMed ID: 791660

  • 1. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [Abstract] [Full Text] [Related]

  • 2. Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1976 Jan; 35(1):161-8. PubMed ID: 1253817
    [Abstract] [Full Text] [Related]

  • 3. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
    Costall B, Naylor RJ.
    Psychopharmacologia; 1975 Jul 23; 43(1):69-74. PubMed ID: 1172258
    [Abstract] [Full Text] [Related]

  • 4. Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system.
    Bartholini G.
    J Pharm Pharmacol; 1976 May 23; 28(5):429-33. PubMed ID: 6752
    [Abstract] [Full Text] [Related]

  • 5. Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors.
    Trout SJ, Kruk ZL.
    Br J Pharmacol; 1992 Jun 23; 106(2):452-8. PubMed ID: 1393270
    [Abstract] [Full Text] [Related]

  • 6. The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1975 May 23; 32(1):87-92. PubMed ID: 1171020
    [Abstract] [Full Text] [Related]

  • 7. On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs.
    Westerink BH, Lejeune B, Korf J, Van Praag HM.
    Eur J Pharmacol; 1977 Mar 21; 42(2):179-90. PubMed ID: 844497
    [Abstract] [Full Text] [Related]

  • 8. Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse.
    Costall B, Eniojukan JF, Naylor RJ.
    Psychopharmacology (Berl); 1985 Mar 21; 86(4):452-7. PubMed ID: 3929317
    [Abstract] [Full Text] [Related]

  • 9. Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
    Costall B, Naylor RJ, Neumeyer JL.
    Eur J Pharmacol; 1975 Mar 21; 31(1):1-16. PubMed ID: 1168579
    [Abstract] [Full Text] [Related]

  • 10. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B, Domeney AM, Naylor RJ, Tyers MB.
    Br J Pharmacol; 1987 Dec 21; 92(4):881-94. PubMed ID: 2962686
    [Abstract] [Full Text] [Related]

  • 11. The production of asymmetry and circling behaviour following unilateral, intrastriatal administration of neuroleptic agents: a comparison of abilities to antagonise striatal function.
    Costall B, Kelly ME, Naylor RJ.
    Eur J Pharmacol; 1983 Dec 09; 96(1-2):79-86. PubMed ID: 6141060
    [Abstract] [Full Text] [Related]

  • 12. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
    See RE, Lynch AM, Sorg BA.
    Neuroscience; 1996 May 09; 72(1):99-104. PubMed ID: 8730709
    [Abstract] [Full Text] [Related]

  • 13. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
    Costall B, Naylor RJ.
    Psychopharmacologia; 1975 Jul 23; 43(1):53-61. PubMed ID: 1099605
    [Abstract] [Full Text] [Related]

  • 14. The mesolimbic system, denervation and the climbing response in the mouse.
    Costall B, Fortune DH, Naylor RJ, Nohria V.
    Eur J Pharmacol; 1980 Aug 29; 66(2-3):207-15. PubMed ID: 6108225
    [Abstract] [Full Text] [Related]

  • 15. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
    Chivers JK, Reavill C, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1988 Sep 29; 40(9):613-9. PubMed ID: 2907027
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1994 Jul 29; 270(1):192-7. PubMed ID: 7913495
    [Abstract] [Full Text] [Related]

  • 17. Regional selectivity of neuroleptic drugs: an argument for site specificity.
    Borison RL, Diamond BI.
    Brain Res Bull; 1983 Aug 29; 11(2):215-8. PubMed ID: 6138135
    [Abstract] [Full Text] [Related]

  • 18. Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens.
    Zivkovic B, Guidotti A, Revuelta A, Costa E.
    J Pharmacol Exp Ther; 1975 Jul 29; 194(1):37-46. PubMed ID: 239221
    [Abstract] [Full Text] [Related]

  • 19. Acute administration of clozapine, thioridazine and metoclopramide increases extracellular DOPAC and decreases extracellular 5-HIAA, measured in the nucleus accumbens and striatum of the rat using in vivo voltammetry.
    Maidment NT, Marsden CA.
    Neuropharmacology; 1987 Jul 29; 26(2-3):187-93. PubMed ID: 2438582
    [Abstract] [Full Text] [Related]

  • 20. [Different effects of typical and atypical neuroleptics on K+-stimulated dopamine release from isolated rat striatum].
    Gaĭnetdinov RR, Budygin EA, Kovalev GI, Kudrin VS, Raevskiĭ KS.
    Biull Eksp Biol Med; 1992 Jul 29; 114(7):47-9. PubMed ID: 1358258
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.